U.S. News & World Report's Best Hospitals

City of Hope Among Nation's Top 10 'Best Hospitals' for Cancer

U.S. News & World Report’s Best Hospital: Specialty Rankings are out for 2022-23, and our drive for excellence in care has been recognized. Jumping six spots from last year, City of Hope is recognized as the seventh “Best Hospital” for cancer in the nation.

While reaching the top 10 is a special honor, City of Hope really prides itself on consistently delivering excellent care over time. With this year’s ranking, it marks 16 years running in which City of Hope has been recognized among the elite cancer centers in the country. This recognition furthers our resolve to create a system that makes leading-edge research, treatment and care more accessible to more patients, families and communities across the country.

The U.S. News & World Report annual ranking is based on such factors as measures of patient safety, volume, risk-adjusted survival, nursing and national reputation among oncology specialists. Additionally, a cancer hospital’s overall score reflects performance in such areas as advanced technologies and designation as a National Cancer Institute comprehensive cancer center, which City of Hope is.

In 2021, City of Hope earned the prestigious Magnet® recognition from the American Nurses Credentialing Center. The Magnet recognition involved a rigorous review and a written submission that demonstrated stellar performance in more than 80 standards. Delegates from the credentialing body visited City of Hope virtually, toured more than 50 units or departments, and listened to comments from over 500 nurses and staff before a decision was made. Only 9 percent of hospitals in the U.S. have a Magnet recognition.

"City of Hope is honored to be recognized by U.S. News & World Report for the quality, innovation and care demonstrated by our extraordinary physicians, nurses, researchers and health care workers," said Robert Stone, City of Hope president, CEO and the Helen and Morgan Chu Chief Executive Officer Distinguished Chair. "While we’re proud of this achievement, we also are gratified by our increasing ability to connect more people to the wondrous era of cancer care innovation taking place today. This recognition furthers our resolve to create a system that makes leading-edge research, treatment and care more accessible to more patients, families and communities across the country."

Best Reputation in the West

Another important factor in this year’s score was reputation. City of Hope remains among the best when it comes to reputation, ranking 11th along with UCSF Health. This important criterion is particularly notable as it is based on the opinion of oncologists from across the nation who are aware of the importance of innovation and expertise in delivering optimal cancer care. They clearly see it in City of Hope.

City of Hope is proud to have been awarded with “high performing” rankings in even more specialties and procedures than previous years. “High performing” means City of Hope is in the top 10% of ranked hospitals for that respective specialty or procedure. Those specialties with this designation in 2022-23 include gastroenterology/gastrointestinal surgery, geriatrics, pulmonology/lung surgery and urology. The adult procedures receiving the “high performing” mark include lung cancer surgery, colon cancer surgery, prostate cancer surgery and ovarian cancer surgery.

Cancer Treatment Centers of America (CTCA), a part of City of Hope, was also recognized by the U.S. News & World Report rankings, with CTCA Atlanta rated “high performing” for lung cancer surgery and prostate cancer surgery, and CTCA Chicago rated “high performing” for lung cancer surgery, prostate cancer surgery and ovarian cancer surgery.

This recognition is the latest milestone in City of Hope’s transformation into a national cancer research and treatment system. Founded 119 years ago, City of Hope has grown substantially in recent years with the expansion of its clinical network in Southern California, addition of genomics leader TGen, launch of its employer cancer care benefits offering AccessHopeTM, the acquisition of CTCA and a new cancer center in Orange County, California, scheduled to open in August 2022. We look to bring the same level of excellence reflected in these ratings to even more patients in California, Arizona, Illinois and Georgia.

To refer a patient, please call 800-826-HOPE or visit CityofHope.org/patients/refer-a-patient.

To enroll a patient on a clinical trial, please call 626-218-1133, or visit  CityofHope.org/research/find-a-clinical-trial for additional information about clinical trials at City of Hope.